Axim Biotechnologies Inc (AXIM)

$0.01 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 30,300
Avg Vol 204,898
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 45%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

AXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 923 4422
Address:
6191 Cornerstone Court, East, Suite 114, San Diego, United States
TexasMarvL
TexasMarvL Mar. 9 at 7:35 PM
$AXIM Just to clarify. I am no longer an investor here. I still follow AXIM out of curiosity. The AXIM Website still exists and has been updated to show the new leadership structure. I will also mention that the Versea Ophthalmics web page no longer mentions T-POC. My assumption is the relationship with Verséa has been terminated. Last I checked AXIM is behind on SEC Filings. https://aximbiotech.com/about/
1 · Reply
javanz
javanz Jan. 25 at 3:15 PM
$AXIM Super Fast: https://scitechdaily.com/light-speed-imaging-a-breakthrough-in-edge-detection/
0 · Reply
javanz
javanz Jan. 25 at 2:42 PM
$AXIM Next Generation: http://opr.news/57cd55ce250123en_us?link=1&client=iosnews
0 · Reply
barry9
barry9 Jan. 22 at 8:16 PM
$AXIM ok
1 · Reply
UCIdidmyDD
UCIdidmyDD Dec. 20 at 9:42 AM
$AXIM another useless board of directors who overpaid a dud ceo. he took the companys assets and of course the lowly shareholders as well mjna gets a nice write off they can never use
0 · Reply
TexasMarvL
TexasMarvL Dec. 13 at 12:48 PM
$AXIM AXIM filed a Form 15. Currently links to TPOC are disabled on the Verséa Ophthalmics website. However, a Video posted yesterday on LinkedIn. It sounds like Verséa Ophthalmics is still talking about their TPOC diagnostic tests. https://www.linkedin.com/posts/ophthopedia_video-vers%C3%A9a-focused-on-diagnostic-technologies-activity-7273073162051805185-pY4-?utm_source=share&utm_medium=member_android I'm not familiar with the rules and laws surrounding bankruptcy and the rights to the company's assets. However this video seems to imply Verséa Ophthalmics will still market the tests. I wonder if a new Sapphire Biotech will rise out of the ashes of the AXIM failures? The IP portfolio still has value even after AXIM goes through bankruptcy.
0 · Reply
elway23
elway23 Nov. 27 at 11:05 AM
$ELAB GUYS $TRIB IS ABOUT TO EXPLODE TODAY $DRUG $AXIM $CERO
1 · Reply
UCIdidmyDD
UCIdidmyDD Oct. 16 at 6:25 AM
$AXIM gl Catalina. its ridiculous that JOhn was allowed to keep his job after his multiple public gaffes on Covid, in interviews. making 35k a month while he fucked up everything he touched. like so many, alcohol seemed to be his downfall. may his loved ones find peace where his investors found a different horror show sorry i dont have a filter
1 · Reply
TexasMarvL
TexasMarvL Oct. 16 at 1:35 AM
$AXIM AXIM Insiders still control the AXIM Intellectual property. I would be curious to watch from a distance if Verséa Ophthalmics is able to join or merge as part owner. However it doesn't seem to matter anymore for the retail investor. The price keeps falling. Maybe that is the plan. It probably makes sense for Verséa to let AXIM go bankrupt and then negotiate a deal with the insiders to take the company private. I will watch from a distance to see what happens. I have always had a positive impression about Catalina Valencia. She must have bought Mr Huemoeller's shares today. It appears she paid way too much for over a million shares today. She paid $28,608.22 for 1,086,216 shares which is 0.0263 per share. She could have bought the same number of shares for $2172.43 today. The only explanation I can think of is she bought the shares from Mr Huemoeller's family. RIP Mr Huemoeller.
1 · Reply
TexasMarvL
TexasMarvL Oct. 15 at 10:37 PM
$AXIM Form 8-K RIP CEO Mr John Huemoeller. Catalina Valencia, 75, replaces Mr Huemoeller as CEO.
2 · Reply
Latest News on AXIM
No data available.
TexasMarvL
TexasMarvL Mar. 9 at 7:35 PM
$AXIM Just to clarify. I am no longer an investor here. I still follow AXIM out of curiosity. The AXIM Website still exists and has been updated to show the new leadership structure. I will also mention that the Versea Ophthalmics web page no longer mentions T-POC. My assumption is the relationship with Verséa has been terminated. Last I checked AXIM is behind on SEC Filings. https://aximbiotech.com/about/
1 · Reply
javanz
javanz Jan. 25 at 3:15 PM
$AXIM Super Fast: https://scitechdaily.com/light-speed-imaging-a-breakthrough-in-edge-detection/
0 · Reply
javanz
javanz Jan. 25 at 2:42 PM
$AXIM Next Generation: http://opr.news/57cd55ce250123en_us?link=1&client=iosnews
0 · Reply
barry9
barry9 Jan. 22 at 8:16 PM
$AXIM ok
1 · Reply
UCIdidmyDD
UCIdidmyDD Dec. 20 at 9:42 AM
$AXIM another useless board of directors who overpaid a dud ceo. he took the companys assets and of course the lowly shareholders as well mjna gets a nice write off they can never use
0 · Reply
TexasMarvL
TexasMarvL Dec. 13 at 12:48 PM
$AXIM AXIM filed a Form 15. Currently links to TPOC are disabled on the Verséa Ophthalmics website. However, a Video posted yesterday on LinkedIn. It sounds like Verséa Ophthalmics is still talking about their TPOC diagnostic tests. https://www.linkedin.com/posts/ophthopedia_video-vers%C3%A9a-focused-on-diagnostic-technologies-activity-7273073162051805185-pY4-?utm_source=share&utm_medium=member_android I'm not familiar with the rules and laws surrounding bankruptcy and the rights to the company's assets. However this video seems to imply Verséa Ophthalmics will still market the tests. I wonder if a new Sapphire Biotech will rise out of the ashes of the AXIM failures? The IP portfolio still has value even after AXIM goes through bankruptcy.
0 · Reply
elway23
elway23 Nov. 27 at 11:05 AM
$ELAB GUYS $TRIB IS ABOUT TO EXPLODE TODAY $DRUG $AXIM $CERO
1 · Reply
UCIdidmyDD
UCIdidmyDD Oct. 16 at 6:25 AM
$AXIM gl Catalina. its ridiculous that JOhn was allowed to keep his job after his multiple public gaffes on Covid, in interviews. making 35k a month while he fucked up everything he touched. like so many, alcohol seemed to be his downfall. may his loved ones find peace where his investors found a different horror show sorry i dont have a filter
1 · Reply
TexasMarvL
TexasMarvL Oct. 16 at 1:35 AM
$AXIM AXIM Insiders still control the AXIM Intellectual property. I would be curious to watch from a distance if Verséa Ophthalmics is able to join or merge as part owner. However it doesn't seem to matter anymore for the retail investor. The price keeps falling. Maybe that is the plan. It probably makes sense for Verséa to let AXIM go bankrupt and then negotiate a deal with the insiders to take the company private. I will watch from a distance to see what happens. I have always had a positive impression about Catalina Valencia. She must have bought Mr Huemoeller's shares today. It appears she paid way too much for over a million shares today. She paid $28,608.22 for 1,086,216 shares which is 0.0263 per share. She could have bought the same number of shares for $2172.43 today. The only explanation I can think of is she bought the shares from Mr Huemoeller's family. RIP Mr Huemoeller.
1 · Reply
TexasMarvL
TexasMarvL Oct. 15 at 10:37 PM
$AXIM Form 8-K RIP CEO Mr John Huemoeller. Catalina Valencia, 75, replaces Mr Huemoeller as CEO.
2 · Reply
insiderbuyingselling
insiderbuyingselling Oct. 15 at 9:27 PM
$AXIM new insider buying: 1086216 shares. http://insiderbuyingselling.com/?t=AXIM
0 · Reply
TexasMarvL
TexasMarvL Oct. 12 at 1:31 PM
$AXIM Is Website shut down? WWW.AXIMEYE.COM This one still works. https://aximbiotech.com/
1 · Reply
TexasMarvL
TexasMarvL Sep. 16 at 11:35 PM
$AXIM Q2 results were a total disaster. Only 1000 tests were sold in Q2 after almost 5000 sold in Q1. On Page 28 of Q2 10-Q go to the bottom and read the last paragraph. Since production started I have only focused on revenue. Last time AXIM management was this quiet they had apparently screwed up manufacturing and after 5 months of silence hired contract manufacturer Auer Precision at the end of December. Auer Precision was a great decision. Q1 sales were very promising. Then the announcement about the Parkinsons disease test. Then absolutely nothing. The Parkinsons disease test was barely mentioned in the Q2 10-Q. I have no clue what AXIM management has screwed up this time. Only 1000 tests sold in Q2. Verséa Ophthalmics new customer announcements on LinkedIn have dropped from one every week to maybe one a month. When AXIM management is this quiet, my guess is they screwed something up.
1 · Reply
Glopez87
Glopez87 Sep. 6 at 4:48 PM
$AXIM 🤣🤣
0 · Reply
Inittowinits
Inittowinits Sep. 5 at 7:02 PM
$AXIM well shit
1 · Reply
javanz
javanz Sep. 1 at 10:48 PM
$AXIM You can see it in the eyes: https://uknow.uky.edu/research/uk-researchers-find-alzheimer-s-brain-changes-long-covid-patients
0 · Reply
TexasMarvL
TexasMarvL Aug. 22 at 3:23 PM
$AXIM Dual test for IgE/MMP-9. Will this test replace the existing IgE test? Cut/Paste from the 2024 Q2 10-Q. On December 13, 2022, AXIM announced the development of a novel dual IgE/MMP rapid ophthalmological diagnostic test for which the Company filed a provisional patent with the US Patent and Trademark Office. The new product offers clinicians an innovative new rapid ophthalmological diagnostic solution designed to reliably measure both Ocular Immunoglobulin E (IgE) and MMP-9 in a single test. The test is slated for further clinical development in the third quarter of 2024 and, once FDA approved, will be added to AXIM’s expanding catalog of ophthalmological diagnostic tools available to clinicians throughout North America.
0 · Reply
TexasMarvL
TexasMarvL Aug. 22 at 3:22 PM
$AXIM New customer from Georgia. https://www.linkedin.com/posts/vers%C3%A9a-ophthalmics_visionsource-tpoctitans-tpoc-activity-7232355952732127232-Hk3g?utm_source=share&utm_medium=member_android
0 · Reply
TexasMarvL
TexasMarvL Aug. 22 at 1:03 PM
$AXIM The Parkinson’s disease test was mentioned only 5 times in the Q2 10-Q. 1) "We developed a tear based POC PD test" 2) "We released a video interview" where we talked about our POC PD test. 3) lastly Parkinsons was mention 3 times in 1 paragraph talking about, "We filed a patent" for our POC PD test.
1 · Reply
UCIdidmyDD
UCIdidmyDD Aug. 21 at 5:23 AM
$AXIM 6000 cash left how does it work from here?
0 · Reply
TexasMarvL
TexasMarvL Aug. 21 at 1:03 AM
$AXIM 10-Q said Q2 revenue fell off a cliff. How long has it been since Verséa Ophthalmics LinkedIn page shared a post about a new #TPOCTITAN customer? These results are a total disaster. Only 1000 tests were sold in Q2. Cut/paste During the quarter ending March 31, 2024 4,550 in tests were shipped at $10 per test resulting in revenue recognition of $45,500 and during the quarter ended June 30, 2024 1,000 tests were shipped resulting in 10,000 revenue recognition; leaving a carrying value of $136,500. There was a verbal agreement to reduce the selling price of the tests from $12- to $10- https://www.otcmarkets.com/filing/html?id=17772267&guid=EvO-ke82wLxnB3h
0 · Reply
Inittowinits
Inittowinits Aug. 21 at 12:54 AM
$AXIM is the volume of 2.9 million accurate?
0 · Reply